Position in PRTA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,847
-$215 QoQ
Shares Held
393
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#147
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. PRTA ranks #155 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in PRTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,847 | 393 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,062 | 418 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,428 | 359 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $3,064 | 314 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $54,818 | 9,031 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $6,336 | 512 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $11,924 | 861 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $13,367 | 799 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $22,930 | 1,111 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $28,039 | 1,132 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $42,190 | 1,161 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $201,781 | 4,182 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $507,866 | 7,438 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $383,397 | 7,910 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $489,109 | 8,118 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $46,139 | 761 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $31,494 | 1,160 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $42,421 | 1,160 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $63,726 | 1,290 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $91,886 | 1,290 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $66,318 | 1,290 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $32,404 | 1,290 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $13,931 | 1,160 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $11,588 | 1,160 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $12,133 | 1,160 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $13,257 | 1,239 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||